These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19681655)

  • 21. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.
    Putignano P; Bertolini M; Losa M; Cavagnini F
    J Endocrinol Invest; 2003 Jun; 26(6):539-44. PubMed ID: 12952368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.
    Mraz M; Bartlova M; Lacinova Z; Michalsky D; Kasalicky M; Haluzikova D; Matoulek M; Dostalova I; Humenanska V; Haluzik M
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):369-75. PubMed ID: 19702724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans.
    Zhang X; Yeung DC; Karpisek M; Stejskal D; Zhou ZG; Liu F; Wong RL; Chow WS; Tso AW; Lam KS; Xu A
    Diabetes; 2008 May; 57(5):1246-53. PubMed ID: 18252893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Blood coagulation function change and influence factors in Cushing's syndrome and obesity].
    Liu Z; Lu L; Chen S; Pan H; Zhu H; Gong F; Yang H; Wang L; Deng K; Yao Y; Feng M; Zhang Y; Xing B; Wang R
    Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(11):850-3. PubMed ID: 27045645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced levels of serum FGF19 and impaired expression of receptors for endocrine FGFs in adipose tissue from HIV-infected patients.
    Gallego-Escuredo JM; Domingo P; Gutiérrez Mdel M; Mateo MG; Cabeza MC; Fontanet A; Vidal F; Domingo JC; Giralt M; Villarroya F
    J Acquir Immune Defic Syndr; 2012 Dec; 61(5):527-34. PubMed ID: 23187887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study.
    Di Somma C; Pivonello R; Loche S; Faggiano A; Klain M; Salvatore M; Lombardi G; Colao A
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):302-8. PubMed ID: 12608935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roux-en-Y Gastric Bypass Surgery Has Unique Effects on Postprandial FGF21 but Not FGF19 Secretion.
    Harris LLS; Smith GI; Mittendorfer B; Eagon JC; Okunade AL; Patterson BW; Klein S
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3858-3864. PubMed ID: 28938478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cushing's Syndrome: Screening and Diagnosis.
    Ceccato F; Boscaro M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome.
    Krsek M; Silha JV; Jezková J; Hána V; Marek J; Weiss V; Stepán JJ; Murphy LJ
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):350-7. PubMed ID: 15009001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
    Friedrich D; Marschall HU; Lammert F
    BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice.
    Albarazanji K; Jennis M; Cavanaugh CR; Lang W; Singh B; Lanter JC; Lenhard JM; Hornby PJ
    Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G653-G667. PubMed ID: 30920846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Plasma leptin levels in relation to body composition and body fat distribution in patients with Cushing's syndrome].
    Robaczyk M; Krzyzanowiska-Swiniarska B; Andrysiak-Mamos E; Kulig G; Pilarska K
    Pol Arch Med Wewn; 2003 Nov; 110(5):1299-308. PubMed ID: 16737000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum total prostate-specific antigen assay in women with Cushing's disease or alcohol-dependent pseudo-Cushing's State.
    Coiro V; Volpi R; Galli P; Manfredi G; Magotti MG; Saccani-Jotti G; Chiodera P
    Horm Res; 2004; 61(3):148-52. PubMed ID: 14685016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma leptin levels do not change in patients with Cushing's disease shortly after correction of hypercortisolism.
    Cizza G; Lotsikas AJ; Licinio J; Gold PW; Chrousos GP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2747-50. PubMed ID: 9253364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of bioassayable and immunoassayable plasma ACTH and cortisol concentrations in normal subjects and in patients with Cushing's disease.
    Krieger DT; Allen W
    J Clin Endocrinol Metab; 1975 Apr; 40(4):675-87. PubMed ID: 165214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual actions of fibroblast growth factor 19 on lipid metabolism.
    Wu X; Ge H; Baribault H; Gupte J; Weiszmann J; Lemon B; Gardner J; Fordstrom P; Tang J; Zhou M; Wang M; Li Y
    J Lipid Res; 2013 Feb; 54(2):325-32. PubMed ID: 23204296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast growth factor 21, adiposity, and macronutrient balance in a healthy, pregnant population with overweight and obesity.
    Sutton EF; Morrison CD; Stephens JM; Redman LM
    Endocr Res; 2018 Nov; 43(4):275-283. PubMed ID: 29768065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status.
    Lee Y; Lim S; Hong ES; Kim JH; Moon MK; Chun EJ; Choi SI; Kim YB; Park YJ; Park KS; Jang HC; Choi SH
    Clin Endocrinol (Oxf); 2014 Jan; 80(1):57-64. PubMed ID: 23278761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.